First human test for new HIV vaccine strategy
Disease control
Completed
This early-stage study tested the safety and immune response of a new DNA vaccine, called ICVAX, in people living with HIV who are stable on their regular medication. It involved 45 participants who received different doses of the vaccine or a placebo. The main goal was to see if…
Phase: PHASE1 • Sponsor: Immuno Cure Holding (HK) Limited • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC